Actively Recruiting
Efficacy of Investigator Product for the Amelioration of Digital Eye Strain in Children
Led by Universiti Sains Malaysia · Updated on 2026-04-29
70
Participants Needed
2
Research Sites
91 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Computer vision syndrome (CVS), also referred to as Digital eye strain (DES), is a group of eye and vision problems caused by prolonged use of electronic devices. The American Optometric Association (APA) defines DES as a group of eye and vision-related problems caused by prolonged computer, tablet, e-reader, and cell phone use. Currently, for more than 20 years, DES has been recognised as a public health issue, and the terms DES are also used to describe the condition, attributed to the wide range of digital devices associated with potential problems.
CONDITIONS
Official Title
Efficacy of Investigator Product for the Amelioration of Digital Eye Strain in Children
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children with Digital Eye Strain (CVS-Q score 6-18)
You will not qualify if you...
- Children with CVS-Q score 19 or higher
- Children who wear contact lenses
- Children with any diagnosed ocular motility disorder or focusing/binocular vision issues
- Participants who are color-blind
- Participants taking retinol or carotenoid supplements
- Participants with immunosuppressive disorders or on immunosuppressive medication
- Participants with atopy or allergic disorders
- Participants with anemia
- Participants who had ophthalmic laser treatment less than 3 months ago
- Participants with systemic diseases linked to dry eye
- Participants with blepharitis
- Participants with liver disorders (chronic liver failure, cirrhosis, hepatitis)
- Participants with kidney disorders (chronic kidney disease, hemodialysis)
- Participants with hematological disorders (anemia, thalassemia, hemophilia)
- Participants with psychiatric disorders or mental retardation (bipolar disorder, depression, schizophrenia)
- Participants with cancer or endocrine disorders (Cushing's disease, gigantism, hyperthyroidism)
- Participants using steroids, chemotherapy, or radiotherapy
- Participants currently enrolled in another supplement program
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Universiti Sains Malaysia Bertam Medical Center
Kepala Batas, Pulau Pinang, Malaysia, 13200
Actively Recruiting
2
Universiti Sains Malaysia Bertam Medical Center
Kepala Batas, Pulau Pinang, Malaysia, 13200
Actively Recruiting
Research Team
L
Lai Kuan Lee, PhD
CONTACT
B
Bakiah Shaharuddin, MMed
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here